Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients
Clinical trial NCT03162874 · COMPLETED
Trial details
- NCT number
- NCT03162874
- Sponsor
- Prexton Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-04
- Primary completion
- 2020-02-19
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.